Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Oncogene ; 36(28): 3964-3975, 2017 07 13.
Artigo em Inglês | MEDLINE | ID: mdl-28288135

RESUMO

The acquisition of an invasive phenotype by epithelial cells occurs through a loss of cellular adhesion and polarity, heralding a multistep process that leads to metastatic dissemination. Since its characterization in 1995, epithelial-mesenchymal transition (EMT) has been closely linked to the metastatic process. As a defining aspect of EMT, loss of cell adhesion through downregulation of E-cadherin is carried out by several transcriptional repressors; key among them the SNAI family of transcription factors. Here we identify for the first time that Lyn kinase functions as a key modulator of SNAI family protein localization and stability through control of the Vav-Rac1-PAK1 (Vav-Rac1-p21-activated kinase) pathway. Accordingly, targeting Lyn in vitro reduces EMT and in vivo reduces metastasis of primary tumors. We also demonstrate the clinical relevance of targeting Lyn as a key player controlling EMT; patient samples across many cancers revealed a strong negative correlation between Lyn and E-cadherin, and high Lyn expression in metastatic tumors as well as metastasis-prone primary tumors. This work reveals a novel pancancer mechanism of Lyn-dependent control of EMT and further underscores the role of this kinase in tumor progression.


Assuntos
Metástase Neoplásica/prevenção & controle , RNA Interferente Pequeno/farmacologia , Fatores de Transcrição da Família Snail/metabolismo , Quinases da Família src/genética , Animais , Linhagem Celular Tumoral , Transição Epitelial-Mesenquimal/efeitos dos fármacos , Transição Epitelial-Mesenquimal/genética , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Camundongos , Terapia de Alvo Molecular , Metástase Neoplásica/genética , Neoplasias/genética , Neoplasias/patologia , Transporte Proteico/efeitos dos fármacos , Transporte Proteico/genética , Ensaios Antitumorais Modelo de Xenoenxerto , Quinases da Família src/antagonistas & inibidores
2.
Opt Express ; 18(25): 25999-6006, 2010 Dec 06.
Artigo em Inglês | MEDLINE | ID: mdl-21164947

RESUMO

We demonstrate 2.6 µm mid-infrared lasing at room temperature in a planar waveguide structure. Planar waveguides were fabricated using pulsed laser deposition (PLD) by depositing chromium doped zinc selenide thin films on sapphire substrate (Cr2+:ZnSe/sapphire). Highly doped Cr2+:ZnSe/Sapphire thin film sample was also used to demonstrate passive Q-switching of Er:YAG laser operating at 1.645 µm.


Assuntos
Cromo/química , Lasers , Oscilometria/instrumentação , Refratometria/instrumentação , Compostos de Selênio/química , Ressonância de Plasmônio de Superfície/instrumentação , Compostos de Zinco/química , Desenho Assistido por Computador , Desenho de Equipamento , Análise de Falha de Equipamento , Raios Infravermelhos
3.
Opt Express ; 17(4): 2048-56, 2009 Feb 16.
Artigo em Inglês | MEDLINE | ID: mdl-19219110

RESUMO

We demonstrate, for the first time, 10 W, Er-fiber laser pumped, pure CW, thermally diffusion doped, polycrystalline Cr(2+):ZnS laser operating at 2380 nm. We also show Littrow-grating, "single-knob", wavelength tuning of the laser spanning 1940-2780 nm spectral range with the maximum output power of 7.4 W near the central wavelength of 2400 nm and above 2 W over 1970-2760 nm wavelength range. The laser performs with 40% real optical- and 43% slope efficiency, and shows no output power roll-off up to the highest available incident pump power of 27 W.


Assuntos
Cromo , Lasers , Refratometria/instrumentação , Sulfetos , Compostos de Zinco , Desenho Assistido por Computador , Desenho de Equipamento , Análise de Falha de Equipamento , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
4.
Opt Express ; 16(6): 4145-53, 2008 Mar 17.
Artigo em Inglês | MEDLINE | ID: mdl-18542511

RESUMO

We demonstrate CW rapidly-tunable (4.5 microm/s), highpower (150 mW), single-longitudinal-mode (120 MHz) single-crystalline Cr(2+):ZnSe laser; CW widely-tunable (2.12-2.77 microm), multi-watt (2 W over 2.3-2.7 microm), polycrystalline Cr(2+):ZnSe laser; CW multi-watt (6 W, at 2.5 microm), highly efficient (48% real efficiency) polycrystalline Cr(2+):ZnSe laser; CW multi-watt (3 W, at 2.5 microm), highly efficient (41% real efficiency) ultra-compact polycrystalline Cr(2+):ZnSe laser; and CW hot-pressed ceramic Cr(2+):ZnSe laser.


Assuntos
Cromo/química , Lasers de Estado Sólido , Compostos de Selênio/química , Compostos de Zinco/química , Desenho de Equipamento , Análise de Falha de Equipamento
5.
Opt Express ; 12(20): 4986-92, 2004 Oct 04.
Artigo em Inglês | MEDLINE | ID: mdl-19484053

RESUMO

For the first time we demonstrate a multiwavelength, ultrabroadband, continuous-wave, tunable, polycrystalline Cr2+:ZnSe spatially-dispersive laser, operating in the near IR spectral region. We show a dual-wavelength operation of the laser, tunable over a 600 nm spectral range (2200-2800 nm), an ultrabroadband operation of the laser, producing a continuous 135 nm wide spectrum centered at 2500 nm, and show a 200 nm wide (2400-2600 nm) multiline, tunable output spectra, consisting of up to 40 spectral lines. We also show simultaneous tuning of a 20-lines ultrabroadband spectrum over a spectral range of 2200-2800 nm.

6.
Opt Lett ; 27(11): 909-11, 2002 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-18026320

RESUMO

Efficient continuous-wave (cw) lasing of Cr(2+):ZnS and Cr(2+):ZnSe crystals in external hemispherical cavities and in a microchip configuration under Er-fiber-laser pumping at room temperature are reported. The key result is what is believed to be the first successful demonstration of cw Cr(2+):ZnS and Cr(2+):ZnSe microchip lasers with maximum output powers of 63 and 100 mW at 2320 and 2520 nm, with slope efficiencies of 53% and 20%, respectively.

7.
Urologiia ; (5): 12-6, 2001.
Artigo em Russo | MEDLINE | ID: mdl-11641971

RESUMO

An experimental study on 12 mongrel dogs was made for assessment of urodynamics of the upper urinary tracts after reconstructive surgery. Ureterohydronephrosis was modelled by cryodestruction, confirmed by x-ray and radionuclide examinations. Urodynamics of the upper urinary tracts was studied by measurements of the intraluminal pressure and at multichannel impedance ureterography under thiopental anesthesia. It was found that reestablishment of normal urine passage after ureteroplasty is not accompanied by urodynamic recovery. Preoperative hyperfunction of the upper urinary tracts and their postoperative hypofunction appeared unfavourable prognostic signs for ureteroplasty outcomes.


Assuntos
Ureter/cirurgia , Sistema Urinário/cirurgia , Procedimentos Cirúrgicos Urológicos/métodos , Animais , Cães , Feminino , Masculino , Urodinâmica/fisiologia
8.
Urol Nefrol (Mosk) ; (1): 38-42, 1999.
Artigo em Russo | MEDLINE | ID: mdl-11149343

RESUMO

3-13-year follow-up results are presented for 83 adult patients operated in childhood for ureterohydronephrosis, hydronephrosis, vesicoureteral reflux. Positive results were obtained in adults operated in early childhood when renal and urinary compensatory mechanisms were stronger. In hydronephrosis and vesicoureteral reflux the results were better than in ureterohydronephrosis. Combined clinical, morphological and experimental investigations have revealed a direct relationship between renal, ureteral functional reserves in adult patients and age of the correcting operation in childhood, degree of intactness of the kidneys and urodynamics, regenerative ability of leiomyocytes.


Assuntos
Hidronefrose/cirurgia , Rim/anormalidades , Procedimentos de Cirurgia Plástica , Ureter/anormalidades , Refluxo Vesicoureteral/cirurgia , Adolescente , Adulto , Feminino , Seguimentos , Humanos , Hidronefrose/congênito , Rim/cirurgia , Masculino , Prognóstico , Reoperação , Fatores de Tempo , Ureter/cirurgia , Refluxo Vesicoureteral/congênito
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA